• Login
    View Item 
    •   Treasures Home
    • Academic Schools and Programs
    • School of Behavioral and Brain Sciences
    • BBS Faculty Research
    • Rypma, Bart
    • View Item
    •   Treasures Home
    • Academic Schools and Programs
    • School of Behavioral and Brain Sciences
    • BBS Faculty Research
    • Rypma, Bart
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Three‐Dimensional Lesion Phenotyping and Physiologic Characterization Inform Remyelination Ability in Multiple Sclerosis

    Thumbnail
    View/Open
    Link to Article (165.7Kb)
    Author
    Sivakolundu, Dinesh K.
    Hansen, Madison R.
    West, Kathryn L.
    Wang, Yeqi
    Stanley, Thomas
    Wilson, Andrew
    McCreary, Morgan
    Turner, Monroe P.
    Pinho, Marco C.
    Newton, Braeden D.
    Guo, Xiaohu
    Rypma, Bart
    Okuda, Darin T.
    Metadata
    Show full item record
    Abstract
    Abstract
    BACKGROUND AND PURPOSE Multiple sclerosis (MS) clinical management is based upon lesion characterization from 2‐dimensional (2D) magnetic resonance imaging (MRI) views. Such views fail to convey the lesion‐phenotype (ie, shape and surface texture) complexity, underlying metabolic alterations, and remyelination potential. We utilized a 3‐dimensional (3D) lesion phenotyping approach coupled with imaging to study physiologic profiles within and around MS lesions and their impacts on lesion phenotypes. METHODS Lesions were identified in 3T T₂‐FLAIR images and segmented using geodesic active contouring. A calibrated fMRI sequence permitted measurement of cerebral blood flow (CBF), blood‐oxygen‐level‐dependent signal (BOLD), and cerebral metabolic rate of oxygen (CMRO₂). These metrics were measured within lesions and surrounding tissue in concentric layers exact to the 3D‐lesion shape. BOLD slope was calculated as BOLD changes from a lesion to its surrounding perimeters. White matter integrity was measured using diffusion kurtosis imaging. Associations between these metrics and 3D‐lesion phenotypes were studied. RESULTS One hundred nine lesions from 23 MS patients were analyzed. We identified a noninvasive biomarker, BOLD slope, to metabolically characterize lesions. Positive BOLD slope lesions were metabolically active with higher CMRO₂ and CBF compared to negative BOLD slope or inactive lesions. Metabolically active lesions with more intact white matter integrity had more symmetrical shapes and more complex surface textures compared to inactive lesions with less intact white matter integrity. CONCLUSION The association of lesion phenotypes with their metabolic signatures suggests the prospect for translation of such data to clinical management by providing information related to metabolic activity, lesion age, and risk for disease reactivation and self‐repair. Our findings also provide a platform for disease surveillance and outcome quantification involving myelin repair therapeutics.
    Description
    Full text access from Treasures at UT Dallas is restricted to current UTD affiliates (use the provided Link to Article). Non UTD affiliates will find the web address for this item by clicking the "Show full item record" link, copying the "dc.relation.uri" metadata and pasting it into a browser.
    URI
    https://hdl.handle.net/10735.1/6705
    Collections
    • CBH Research
    • Guo, Xiaohu
    • Rypma, Bart

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of TreasuresCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV